ライフサイエンスコーパス: pulmonary nodule

1 apulmonary malignant neoplasm and a solitary pulmonary nodule.

2 here was a nonspecific 3-mm right lower lobe pulmonary nodule.

3 choices about whether to perform biopsy of a pulmonary nodule.

4 s made by fine-needle aspiration biopsy of a pulmonary nodule.

5 section thickness, and 0.6-mm interval) for pulmonary nodules.

6 ssification of benign and malignant solitary pulmonary nodules.

7 specificity for histopathologic diagnosis of pulmonary nodules.

8 eful but expensive test to diagnose solitary pulmonary nodules.

9 been successfully used to investigate single pulmonary nodules.

10 widespread application in the assessment of pulmonary nodules.

11 performed in 116 patients for assessment of pulmonary nodules.

12 distinction of benign and malignant solitary pulmonary nodules.

13 gram that indicates areas that may represent pulmonary nodules.

14 experienced radiologists for the presence of pulmonary nodules.

15 nt peptide reduced the number of established pulmonary nodules.

16 tecting malignancy in indeterminate solitary pulmonary nodules.

17 with radiographically indeterminate solitary pulmonary nodules.

18 the chest showed a mixed response among the pulmonary nodules.

19 dentified multiple nonspecific subcentimeter pulmonary nodules.

20 mprove the quality of care for patients with pulmonary nodules.

21 standardized uptake value (SUV), and size of pulmonary nodules.

22 ction of appreciable number of indeterminate pulmonary nodules.

23 ing (IMI) can improve detection of malignant pulmonary nodules.

24 he management of patients with indeterminate pulmonary nodules.

25 uld be used to measure the volumes of larger pulmonary nodules.

26 mprovement in the detection of subcentimeter pulmonary nodules.

27 n, seven women; age range, 40-75 years) with pulmonary nodules.

28 radiographs, 20 with a solitary uncalcified pulmonary nodule 1-2 cm in diameter, and 20 with fibroti

29 TSC/LAM had higher frequency of noncalcified pulmonary nodules (12% vs 1%, P<.01), hepatic (33% vs 2%

30 arched for data on gross specimens revealing pulmonary nodules 3 cm or smaller.

31 Spherical and lobulated pulmonary nodules 3-15 mm in diameter were placed in a c

32 her HRCT findings were: consolidation (63%), pulmonary nodules (31.4%), mediastinal and/or hilar lymp

33 high sensitivity for the detection of small pulmonary nodules (4-8 mm) and outperformed a three-dime

34 Multiple pulmonary nodules (96%) were the most common CT findings

35 he linear caliper measurements overestimated pulmonary nodule and surface nodule size by a median of

36 Characteristics of pulmonary nodules and additional findings were tabulated

37 e superior to helical scans to help identify pulmonary nodules and characterize them as peribronchova

38 creased diagnostic accuracy for detection of pulmonary nodules and fibrosis.

39 esection, IMI was utilized to evaluate known pulmonary nodules and identify synchronous lesions.

40 te noninvasive imaging test for diagnosis of pulmonary nodules and larger mass lesions, although few

41 study was to evaluate the detection rate of pulmonary nodules and lung cancer in the initial, helica

42 Pulmonary nodules and nodular infiltrates occur frequent

43 The frequency of solid and part-solid pulmonary nodules and the lung cancer diagnoses using an

44 The frequency of solid and part-solid pulmonary nodules and the rate of lung cancer diagnosis

45 Indeterminate pulmonary nodules are a common radiographic finding and

46 Incidental pulmonary nodules are an increasingly common consequence

47 Pulmonary nodules are common incidental findings, but in

48 Solitary pulmonary nodules are common, often incidental findings

49 Because pulmonary nodules are found in up to 25% of patients und

50 est computed tomography scans, indeterminate pulmonary nodules are frequently detected as an incident

51 Pulmonary nodules are frequently detected during diagnos

52 Nearly one-third of solitary pulmonary nodules are radiographically indeterminate for

53 Using patients with pulmonary nodules as a study model, we hypothesized that

54 ischner Society guidelines for management of pulmonary nodules as solid, part solid with a solid comp

55 One patient remains alive with stable pulmonary nodules at 28+ months.

56 In patients with AIDS who have multiple pulmonary nodules at CT, nodule size and distribution ar

57 es suggest the need for better predictors of pulmonary nodules being malignant or benign, so as to re

58 thyroid, myocardium) and malignant lesions (pulmonary nodules, bone lesions); the regression line wa

59 distinguishing between benign and malignant pulmonary nodules by use of features extracted from CT,

60 tion of the pneumonia often leaves calcified pulmonary nodules, calcified mediastinal lymph nodes, or

61 Transthoracic needle biopsy of small pulmonary nodules can produce diagnostic yields comparab

62 Pulmonary nodule characterization is currently being red

63 was no difference in diagnostic accuracy for pulmonary nodules compared with lesions of any size (P =

64 t surgery, an attempt was made to excise any pulmonary nodule considered suspicious for carcinoma at

65 nary nocardiosis presents mainly as multiple pulmonary nodules, consolidations, and cavity in both im

66 Upon detection of a pulmonary nodule (day 67 p.t.), a bronchoalveolar lavage

67 iagnostic CT was performed in 747 suspicious pulmonary nodules detected at low-dose CT screening (17

68 cer and risk stratification in patients with pulmonary nodules detected by CT.

69 ging, and conventional chest radiography for pulmonary nodule detection and management.

70 An automated pulmonary nodule detection program that takes advantage

71 Performance of an automated pulmonary nodule detection program was evaluated on mult

72 ond highest for lesion detectability in most pulmonary nodule evaluation cases.

73 tee with expertise in lung cancer screening, pulmonary nodule evaluation, and implementation science.

74 nt advocates reviewed available evidence for pulmonary nodule evaluation, characterized six focus are

75 Chest radiographs revealed lymphadenopathy, pulmonary nodules, focal consolidation, reticular opacit

76 s (n = 8) were assessed for lymphadenopathy, pulmonary nodules, focal consolidation, reticular or gra

77 Pulmonary nodule follow-up is the most common cause for

78 One hundred fifteen pulmonary nodules for which two thin-section small-field

79 solid, intermediate-sized, intraparenchymal pulmonary nodules found at baseline screening for lung c

80 osine kinase Syk in TSC2-deficient cells and pulmonary nodules from lymphangioleiomyomatosis patients

81 tic patients with histopathologically proven pulmonary nodules greater than 15 mm, the mentioned lesi

82 contrast agent (OTL38) can improve malignant pulmonary nodule identification when combined with PET.

83 Low-dose CT is acceptable for pulmonary nodule identification, making it suitable for

84 IMI identified 56 of 59 (94.9%) malignant pulmonary nodules identified by preoperative imaging.

85 differentiate benign and malignant solitary pulmonary nodules in 61 patients with radiographically i

86 to discriminate between benign and malignant pulmonary nodules in a prospective, multicenter trial.

87 o cases in patients presenting with multiple pulmonary nodules in a setting of immunocompromise and o

88 CT most commonly demonstrated pulmonary nodules in immunocompetent patients with pulmo

89 A disappearing or persistent solid pulmonary nodule is a neglected clinical entity that sti

90 an alternative approach for determining if a pulmonary nodule is a primary lung adenocarcinoma.

91 The imaging evaluation of a solitary pulmonary nodule is complex.

92 approach to the management of patients with pulmonary nodules is evolving as technologies develop.

93 The investigation of pulmonary nodules is time-consuming and often leads to p

94 Small pulmonary nodules < 7 mm were not considered to require

95 spectively collected 92 consecutive cases of pulmonary nodules (<3 cm) in patients who underwent both

96 pted clinical tool in patients with solitary pulmonary nodules, lung cancer, colorectal cancer, melan

97 Seventy-eight pulmonary nodules (mean diameter, 1.5 cm; range, 0.5-3.5

98 who underwent CT-guided biopsy of subpleural pulmonary nodules measuring up to 2 cm in diameter were

99 atients with thoracic lesions, predominately pulmonary nodules, measuring 0.7-5.2 cm (mean, 1.6 cm) u

100 of malignancy associated with subcentimeter pulmonary nodules (micronodules) in patients with malign

101 infection presenting as multiple spiculated, pulmonary nodules mimicking cancer for which the patient

102 d intrathoracic PTLD manifesting as multiple pulmonary nodules (n = 10), a solitary nodule (n = 3), a

103 abnormal findings on the chest CT scan were pulmonary nodules (n = 14), followed by cysts (n = 6) an

104 The most common CT finding was pulmonary nodules (n = 9).

105 icantly strong correlation between SUVmax of pulmonary nodules obtained with PET/CT and that obtained

106 h resolution CT (HRCT) was performed for 118 pulmonary nodules of the adenocarcinoma spectrum surgica

107 ly predict the presence of EGFR mutations in pulmonary nodules of the adenocarcinoma spectrum.

108 Six patients had pulmonary nodules, one of which was calcified at chest r

109 The carcinomas most commonly manifest as a pulmonary nodule or mass on chest radiographs, with more

110 tial treatment recommendation for suspicious pulmonary nodules or lung cancer.

111 common findings resulting in follow-up were pulmonary nodules or masses (559 of 1558, 35.9%), other

112 ions; enrolled at least 10 participants with pulmonary nodules or masses, including at least 5 partic

113 n Society of Clinical Oncology measured five pulmonary nodule phantoms that ranged in size from 1.76

114 ther findings assessed included noncalcified pulmonary nodules, pleural effusion, thoracic duct dilat

115 Pulmonary nodules (PNs) are often detected incidentally

116 In detecting pulmonary nodules, radiologists perform comparably with

117 findings or as major abnormalities, such as pulmonary nodules, requiring further diagnostic evaluati

118 A single pulmonary nodule resected at VATS was more likely to be

119 All adult patients with a new, noncalcified pulmonary nodule seen on chest radiograph.

120 Resolving pulmonary nodules share CT features with malignant nodul

121 is suggests that management of patients with pulmonary nodules should begin with estimating the prete

122 l loop planimeter measurements overestimated pulmonary nodule size and surface nodule size by a media

123 e and is based on conventional criteria (eg, pulmonary nodules, skeletal metastases, and lymphadenopa

124 6 months were reviewed to find patients with pulmonary nodules smaller than 1 cm in long axis for whi

125 The solitary pulmonary nodule (SPN) has always been a diagnostic chal

126 The solitary pulmonary nodule (SPN) is a common radiologic abnormalit

127 and CT in the characterization of a solitary pulmonary nodule (SPN).

128 ents who present with indeterminate solitary pulmonary nodules (SPN).

129 Solitary pulmonary nodules (SPNs) are commonly identified by ches

130 cancer worldwide, usually presents as solid pulmonary nodules (SPNs) on early diagnostic images.

131 PET are widely used to characterize solitary pulmonary nodules (SPNs).

132 ents (aged 65 +/- 14 y) underwent PET/CT for pulmonary nodule staging (mean, 11 +/- 7 mm; range, 5-18

133 on also resulted in significant reduction of pulmonary nodules, suggesting that regulation of invasio

134 Eighteen pulmonary nodules suspicious for lung cancer were found

135 recommended for the noninvasive diagnosis of pulmonary nodules suspicious for lung cancer.

136 nostic yield in the assessment of peripheral pulmonary nodules than navigational bronchoscopy with a

137 able to differentiate benign from malignant pulmonary nodules than were the CAD schemes based on PET

138 ermined the incidence of malignancy among 81 pulmonary nodules that were sampled at biopsy within 3 w

139 These patients had pulmonary nodules that were surgically resected and whic

140 From raw CT data in 10 patients with pulmonary nodules, three sets of CT images were reconstr

141 6-88 y) with 38 known or suspected malignant pulmonary nodules underwent PET of the thorax at 2 time

142 Three-dimensional methods for quantifying pulmonary nodule volume at computed tomography (CT) and

143 A solitary pulmonary nodule was found in the right middle lobe whic

144 vestigation of screen-detected non-calcified pulmonary nodules was guided by ELCAP recommendations, w

145 The incidence of pulmonary nodules was increased in the cyclosporine-trea

146 e surgery, 30 patients with an indeterminate pulmonary nodule were intravenously administered a folat

147 In seven patients, discrete, 1-2-cm pulmonary nodules were detected at CT.

148 Pulmonary nodules were detected in 921 (46%) subjects.

149 Pulmonary nodules were found in about one-third of patie

150 fter baseline CT scanning, 2,832 uncalcified pulmonary nodules were identified in 1,049 participants

151 review board-approved prospective study, 82 pulmonary nodules were identified in eight patients with

152 Pulmonary nodules were more common in women with cysts (

153 rate, and sites of recurrence and number of pulmonary nodules were recorded.

154 racic computed tomography (CT) for suspected pulmonary nodules were recruited to undergo both digital

155 tained in 60 patients with AIDS and multiple pulmonary nodules were reviewed retrospectively by two t

156 Radiologically indeterminate 7-30-mm pulmonary nodules were studied in 107 patients with mali

157 t PTNB can be safely used for the work-up of pulmonary nodules when there is a suspicion of lung canc

158 aximum standardized uptake value (SUVmax) in pulmonary nodules with a diameter of at least 1 cm was c

159 take on PET and scattered diffuse 1- to 2-mm pulmonary nodules with ground-glass opacities ( Fig 1 ).

160 Fifty patients with pulmonary nodules with imaging features suspicious for m

161 of abnormalities detected and classified as pulmonary nodules, with differences of up to more than t

162 cal thinning and multiple bilateral PET-avid pulmonary nodules, with the largest in the left upper lu